Research

rs662 — PON1 Q192R

Affects paraoxonase-1 enzyme activity for detoxifying organophosphates and protecting LDL from oxidation

Moderate Risk Factor

Details

Gene
PON1
Chromosome
7
Risk allele
G
Protein change
p.Gln192Arg
Consequence
Missense
Inheritance
Codominant
Clinical
Risk Factor
Evidence
Moderate
Chip coverage
v3 v4 v5

Population Frequency

AA
35%
AG
48%
GG
17%

Ancestry Frequencies

east_asian
66%
african
57%
latino
38%
south_asian
33%
european
25%

PON1 Q192R — Your HDL's Antioxidant Power

Paraoxonase-1 (PON1) is an enzyme that rides on HDL particles11 HDL particles
High-density lipoprotein, often called "good cholesterol," transports cholesterol from tissues back to the liver
in your bloodstream, where it performs two critical jobs: detoxifying organophosphate pesticides22 organophosphate pesticides
Compounds widely used in agriculture that can be neurotoxic; PON1 breaks down their active metabolites
and protecting LDL cholesterol from oxidative damage33 oxidative damage
Oxidized LDL is a key driver of atherosclerosis, the buildup of plaques in artery walls
. The Q192R variant creates two functionally different versions of the enzyme with a striking tradeoff: the R variant is better at breaking down pesticides, while the Q variant is superior at preventing LDL oxidation and protecting against cardiovascular disease.

The Mechanism

The Q192R polymorphism results from an A>G nucleotide change that exchanges an arginine (R) for glutamine (Q) at position 192 of the protein . This amino acid substitution alters the enzyme's active site44 active site
The region of an enzyme where substrates bind and chemical reactions occur
, changing its catalytic efficiency for different substrates.

The Q isoform can reduce copper-mediated LDL oxidation by 58-61%, whereas the R genotype inhibits LDL oxidation by only 36-48% . However, the situation reverses for organophosphate metabolism— purified PON192 alloforms show the R variant has higher catalytic efficiency for hydrolysis of specific oxon substrates , making RR individuals better protected against pesticide poisoning but more vulnerable to cardiovascular disease.

The Evidence

The cardiovascular implications are substantial.

In a Saudi study of 2,456 individuals, the RR genotype was associated with CAD risk with an OR of 2.2 (95% CI 1.4-7.4, p < 0.01), independent of age, gender, smoking, obesity, and diabetes .

In Chinese Han individuals, after adjusting for conventional risk factors, 192R allele carriers had a significantly higher risk of CAD than other allele carriers . The mechanism is clear: the diminished ability of the RR variant genotype of PON1 to blunt LDL oxidation allows oxidized LDL to accumulate in artery walls.

Interestingly, the cardiovascular risk associated with the R allele shows ethnic variation55 ethnic variation
Genetic risk can vary across populations due to differences in genetic background and environmental exposures
.

In Asian populations, the 192R allele was a susceptible factor for type 2 diabetes, but represented a protective factor in the European population (OR = 0.66, 95% CI = 0.45-0.98) under a heterozygous genetic model . This may reflect different patterns of oxidative stress, diet, or gene-gene interactions across populations.

For organophosphate exposure, the evidence is also compelling.

A meta-analysis of nine studies with 1,042 patients showed that the PON1 192Q polymorphism increases the risk of organophosphate toxicity , with significant associations among Caucasian populations .

In Colombian coffee harvesters, the 192Q genotype was associated with hypertension , potentially reflecting both cardiovascular vulnerability and cumulative pesticide exposure effects.

Practical Implications

Your genotype shapes how your body handles two distinct challenges: protecting your arteries from oxidative damage and clearing environmental toxins. QQ individuals have superior antioxidant protection but are more vulnerable to organophosphate toxicity. RR individuals have the opposite profile—better pesticide clearance but reduced cardiovascular protection. Heterozygotes (QR) fall somewhere in between.

For cardiovascular health, tomato juice consumption reduced LDL oxidation and improved antioxidant status in R-allele carriers, but not in the QQ genotype group , suggesting dietary antioxidants may compensate for the R variant's reduced intrinsic antioxidant capacity. Polyphenol-rich foods (berries, green tea, dark chocolate, olive oil) provide similar oxidized LDL protection.

If you have occupational or recreational exposure to organophosphate pesticides (agricultural work, home gardening with conventional pesticides), your Q192R genotype affects your vulnerability. QQ individuals should be especially cautious about pesticide exposure, using protective equipment and favoring organic produce when practical.

Interactions

The Q192R polymorphism interacts with PON1 L55M (rs854560)66 PON1 L55M (rs854560)
Another PON1 variant affecting enzyme expression levels; the M allele is associated with lower PON1 concentrations
in the same gene.

The 55M homozygotes have over 50% less activity toward paraoxon compared to the LL and LM genotypes regardless of the 192 genotype, and the 55 polymorphism accounts for 16% of the variation in PON1 activity . The combination of Q192R with unfavorable L55M genotypes compounds cardiovascular risk and pesticide sensitivity.

In rheumatoid arthritis patients, the TLQ haplotype (combining promoter, L55M, and Q192R variants) was associated with low PON1 activity (OR = 2.29) and low PON1 protein levels (OR = 1.65) , demonstrating how multiple PON1 variants can synergistically impair enzyme function.

Nutrient Interactions

antioxidants altered_metabolism

Genotype Interpretations

What each possible genotype means for this variant:

AA “Enhanced Antioxidant” Normal

Superior LDL protection, reduced organophosphate clearance

You have two copies of the Q variant (192QQ genotype), which produces the most effective form of PON1 for preventing LDL oxidation and protecting against atherosclerosis. This genotype is present in approximately 35% of European populations but is much less common in East Asian populations (around 12%). Your PON1 enzyme can reduce copper-mediated LDL oxidation by 58-61%, compared to only 36-48% for the RR genotype. This provides superior cardiovascular protection but comes with a tradeoff: you have lower paraoxonase activity toward organophosphate pesticides, making you more vulnerable to toxicity from agricultural chemicals and certain nerve agents.

AG “Intermediate Metabolizer” Intermediate Caution

Balanced organophosphate detoxification and LDL protection

The heterozygous state produces both Q and R forms of the enzyme, which may provide functional flexibility. Studies show that heterozygotes often have intermediate phenotypes for both paraoxonase activity and LDL protection. The relative expression of each allele may vary between individuals due to other genetic and environmental factors, leading to a range of enzyme activities within the QR genotype group. This balanced profile may actually be advantageous in environments with mixed exposures to both oxidative stress and organophosphates.

GG “Enhanced Detoxifier” Reduced Warning

Superior organophosphate clearance, reduced cardiovascular protection

The arginine at position 192 creates an enzyme active site optimized for organophosphate hydrolysis but compromised for lipid peroxide breakdown. This reflects an evolutionary tradeoff that may have been advantageous in agricultural populations with high pesticide exposure but is detrimental in modern environments where oxidative stress from diet and lifestyle is the primary threat. The RR genotype has been independently associated with CAD risk even after adjusting for conventional risk factors like smoking, obesity, diabetes, and lipid levels, suggesting PON1's antioxidant function is a distinct cardiovascular risk pathway.

Key References

PMID: 23625196

RR genotype associated with CAD risk (OR 2.2) independently of traditional risk factors in Saudi population

PMID: 24918121

Meta-analysis of 2,456 subjects showing 192R allele carriers have significantly higher CAD risk than Q allele carriers

PMID: 26091975

Higher PON1 activity associated with decreased oxidized LDL levels in Finnish population

PMID: 23590198

Meta-analysis showing PON1 192Q and 55L polymorphisms increase organophosphate toxicity risk

PMID: 29314660

Meta-analysis finding 192R protective for T2DM in Europeans but risk factor in South/East Asians